Neoplasms

All Conditions

Digestive System Diseases

Wounds and Injuries

Symptoms and General Pathology

Carcinoma

Carcinoma, Hepatocellular

Rupture

Rupture, Spontaneous

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Adenocarcinoma

Liver Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Liver Diseases

Pathological Conditions, Anatomical

Hematinics

All Drugs and Chemicals

Liver Extracts

Bilirubin

Patients who received liver resection or palliative surgery, such as microwave coagulation therapy, hepatic artery ligation, or suturing ligation.

Patients who received transcatheter arterial embolization (or transcatheter arterial chemoembolization) or conservative treatment

Liver resection was comprised of single or multiple liver resections aiming to excise all macroscopic tumors.

Liver resection

Transcatheter arterial embolization or transcatheter arterial chemoembolization can localize the bleeding point and provide interventional embolization.

Transcatheter arterial embolization

Xiao-ping Chen, Prof. PHD

To compare Child-Pugh and Albumin-Bilirubin scores in patients with spontaneous rupture of hepatocellular carcinoma

To compare Child-Pugh and Albumin-Bilirubin scores in patients with spontaneous rupture of hepatocellular carcinoma. And to determine which is better in predicting long-term survival and short-term survival.

A Comparison Between Child-Pugh and Albumin-Bilirubin Scores

A Comparison Between Child-Pugh and Albumin-Bilirubin Scores in Patients With Spontaneous Rupture of Hepatocellular Carcinoma: A Retrospective Study

Overall survival of all patients among different Child-Pugh and albumin-bilirubin scores

Ninety-day mortality of all patients among different Child-Pugh and albumin-bilirubin scores

Ninety-day mortality of the surgical subgroup among different Child-Pugh and albumin-bilirubin scores

Ninety-day mortality of the non-surgical subgroup among different Child-Pugh and albumin-bilirubin scores

Huazhong University of Science and Technology

Professor

Cinobufacin by Perfusion of Hepatic Artery Combining the Arterial Embolotherapy

Cinobufacin injection

changquan Ling, Doctor

Ling chang quan, doctor

Cinobufacini has the effects of anticancer, improving the liver function, elevation of immunity and little side effects, and is important and significant for the patients with hepatitis, liver cirrhosis and hepatomas.

Compared with transarterial chemoembolization (TACE) , the clinical effect of cinobufacini is non-inferior/ equivalent.Compared with TACE, cinobufacini is superior in security .

Inclusion criterion :

1. The sex does not limit, age:18-70 years old .
2. The patients have inoperable advanced hepatoma without serious disorder in liver and renal, tumor occupation\< 70 %
3. The patients have failure in surgical intervention or resection operation recidivist
4. Hepatic function Child-pugh A、B
5. All the cases have the definite final diagnosis of imageology results such as MRI、CT 、B ultrasonic or cytology results
6. The patient's prediction of live time\>6 months, who can tolerant of TACE and has quality of life ECOG score\<3
7. The patients participate the clinical trial voluntarily and have already signed informed consent

Exclusion criterion :

1. Main portal vein was obstructed completely.
2. The occupation of tumor are 70 % or more than 70 % in the whole liver
3. The patient has TACE or other antineoplaston
4. After carcinosectomy the patient has the prophylactic
5. The patient is with renal inadequacy: Cr≥133 umol/L
6. Severe cardiovascular disease
7. The patient is with other diseases to influence the proposal

Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy

The Clinical Research of the Intermediate and Advanced Hepatoma Treated by Cinobufacin by Perfusion of Hepatic Artery Combining the Arterial Embolotherapy

The evaluation of the patient's respondence for the therapy is carried out every phase, according to RECIST:CR,PR,SD and PD.

Changhai Hospital

Changquan Ling

Musculoskeletal Diseases

Hemorrhage

Neoplasm Metastasis

Blood Loss, Surgical

Spinal Neoplasms

Neoplasms, Second Primary

Neoplastic Processes

32 patients with spinal metastasis/metastases will undergo arteriography and receive transcatheter arterial embolization of spinal metastasis/metastases 0-48 hours prior to surgery.

32 patients with spinal metastasis/metastases will undergo arteriography of spinal metastasis/metastases without receiving transcatheter arterial embolization prior to surgery.

Arteriography and transcatheter arterial embolization of spinal metastasis/metastases 0-48 hours prior to surgery.

Arteriography and preoperative embolization

Arteriography of spinal metastasis/metastases without transcatheter arterial embolization prior to surgery.

Arteriography

Lars Lönn, MD, Ph.d.

The main purpose of this study is to assess the efficacy of preoperative embolization in decreasing operative blood loss, decreasing the need for intraoperative transfusion and facilitate surgical resection in metastatic spine surgery. Furthermore the study aims at describing the vascularity in a series of spinal metastasis, and to correlate this with perioperative blood loss.

Preoperative Embolization in Surgical Treatment of Spinal Metastases.

Preoperative Embolization in Surgical Treatment of Spinal Metastases. A Randomized Controlled Trial.

Defined as the amount of time (measured in minutes) from skin incision to skin closure.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Comparison Between Child-Pugh and Albumin-Bilirubin Scores	NCT03534843	Rupture, Sponta... Rupture Liver Hepatocellular ... Hepatic Impairm...	Liver resection Transcatheter a...	15 Years - 76 Years	Huazhong University of Science and Technology
Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy	NCT01236690	Hepatoma Cinobufacin Inj...	Cinobufacin inj...	18 Years - 70 Years	Changhai Hospital
Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy	NCT01236690	Hepatoma Cinobufacin Inj...	Cinobufacin inj...	18 Years - 70 Years	Changhai Hospital
Preoperative Embolization in Surgical Treatment of Spinal Metastases.	NCT01365715	Spinal Metastas...	Arteriography a... Arteriography	18 Years -	Rigshospitalet, Denmark

Spots Global Cancer Trial Database for transcatheter arterial embolization